| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |